Cargando…
P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430614/ http://dx.doi.org/10.1097/01.HS9.0000846628.17113.b2 |
| _version_ | 1784779819710414848 |
|---|---|
| author | Suvannasankha, A. Bahlis, N. Trudel, S. Weisel, K. Koenecke, C. Oriol, A. Voorhees, P. M. Alonso, A. A. Callander, N. S. Mateos Manteca, M. V. Reddy, N. Hakim, S. Patel, N. Williams, D. Jewell, R. C. Zhou, X. Gupta, I. Nooka, A. K. |
| author_facet | Suvannasankha, A. Bahlis, N. Trudel, S. Weisel, K. Koenecke, C. Oriol, A. Voorhees, P. M. Alonso, A. A. Callander, N. S. Mateos Manteca, M. V. Reddy, N. Hakim, S. Patel, N. Williams, D. Jewell, R. C. Zhou, X. Gupta, I. Nooka, A. K. |
| author_sort | Suvannasankha, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430614 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306142022-08-31 P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY Suvannasankha, A. Bahlis, N. Trudel, S. Weisel, K. Koenecke, C. Oriol, A. Voorhees, P. M. Alonso, A. A. Callander, N. S. Mateos Manteca, M. V. Reddy, N. Hakim, S. Patel, N. Williams, D. Jewell, R. C. Zhou, X. Gupta, I. Nooka, A. K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430614/ http://dx.doi.org/10.1097/01.HS9.0000846628.17113.b2 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Suvannasankha, A. Bahlis, N. Trudel, S. Weisel, K. Koenecke, C. Oriol, A. Voorhees, P. M. Alonso, A. A. Callander, N. S. Mateos Manteca, M. V. Reddy, N. Hakim, S. Patel, N. Williams, D. Jewell, R. C. Zhou, X. Gupta, I. Nooka, A. K. P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY |
| title | P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY |
| title_full | P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY |
| title_fullStr | P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY |
| title_full_unstemmed | P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY |
| title_short | P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY |
| title_sort | p940: safety and clinical activity of belantamab mafodotin with pembrolizumab in patients with relapsed/refractory multiple myeloma (rrmm): dreamm-4 study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430614/ http://dx.doi.org/10.1097/01.HS9.0000846628.17113.b2 |
| work_keys_str_mv | AT suvannasankhaa p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT bahlisn p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT trudels p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT weiselk p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT koeneckec p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT oriola p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT voorheespm p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT alonsoaa p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT callanderns p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT mateosmantecamv p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT reddyn p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT hakims p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT pateln p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT williamsd p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT jewellrc p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT zhoux p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT guptai p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study AT nookaak p940safetyandclinicalactivityofbelantamabmafodotinwithpembrolizumabinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm4study |